STOCK TITAN

Freshpet (FRPT) CEO exercises 168K options, sells stock under plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) reported that Chief Executive Officer and director William B. Cyr and related entities exercised options and sold shares in August 2026. Over August 21 and 24, they exercised 168,000 options at $10.23 per share into common stock and sold 87,905 shares in open-market transactions at prices around $73.8–$76.0 per share. The sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025, and the options were granted under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested by December 31, 2020.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 87,905 shs ($6.58M)
Approx. gross sale proceeds $6.58M
Approx. exercise cost $1.72M
Type Security Shares Price Value
Exercise Options to purchase common stock F4 62,369 $0.00 $0.00
Exercise Options to purchase common stock F4 4,620 $0.00 $0.00
Exercise Options to purchase common stock F4 9,030 $0.00 $0.00
Exercise Options to purchase common stock F4 7,981 $0.00 $0.00
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock F1 40,398 $76.01 $3.07M
Sale Common Stock F1 567 $74.03 $42K
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock F1 640 $74.03 $47K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock F1 1,250 $74.03 $93K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock F1 1,105 $74.03 $82K
Exercise Options to purchase common stock F4 62,369 $0.00 $0.00
Exercise Options to purchase common stock F4 4,620 $0.00 $0.00
Exercise Options to purchase common stock F4 9,030 $0.00 $0.00
Exercise Options to purchase common stock F4 7,981 $0.00 $0.00
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock F1, F2, F3 40,957 $73.87 $3.03M
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock F1 639 $74.34 $48K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock F1 1,247 $74.34 $93K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock F1 1,102 $74.34 $82K
Holdings After Transaction: Options to purchase common stock — 56,441 shares (Direct); Options to purchase common stock — 4,180 shares (Indirect, By Spouse); Options to purchase common stock — 8,170 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Options to purchase common stock — 7,209 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants); Common Stock — 331,309 shares (Direct); Common Stock — 45,432 shares (Indirect, By Spouse); Common Stock — 99,470 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Common Stock — 90,447 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants)
Footnotes (4)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.819 to $73.874.
  3. F3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
  4. F4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Options exercised 168,000 shares Total derivative exercises (code M) reported in transactionSummary
Shares sold 87,905 shares Total sell transactions (code S) reported in transactionSummary
Option exercise price $10.23 per share Conversion or exercise price for options to purchase common stock
Highest reported sale price $76.0100 per share Common stock sale on August 24, 2026
Representative sale price $73.8700 per share Weighted-average sale on August 21, 2026, footnote-qualified
10b5-1 plan adoption date November 5, 2025 Date CEO adopted Rule 10b5-1 trading plan governing reported sales
Derivative transaction count 8 transactions Total derivative (option) transactions reported
Net buy/sell direction net-sell of 87,905 shares transactionSummary netBuySellShares and netBuySellDirection
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
2014 Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan."

FAQ

What did Freshpet (FRPT) CEO William B. Cyr report in this Form 4?

William B. Cyr and related entities exercised 168,000 stock options at $10.23 and sold 87,905 shares of Freshpet common stock in open-market transactions on August 21 and 24, 2026.

How many Freshpet (FRPT) shares were sold and at what prices?

A total of 87,905 shares of Freshpet common stock were sold. Reported sale prices include $73.8700, $74.0300, $74.3400, and $76.0100 per share, with one sale reported at a weighted average price within a range of $73.819–$73.874.

How many Freshpet (FRPT) options did the CEO exercise and at what exercise price?

The CEO and related entities exercised 168,000 options to purchase Freshpet common stock. The options carried an exercise price of $10.23 per share and were issued under Freshpet’s 2014 Omnibus Incentive Plan.

Were the Freshpet (FRPT) stock sales under a Rule 10b5-1 plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025, indicating the trades were pre-arranged under that plan.

Which accounts or entities were involved in the Freshpet (FRPT) transactions?

Transactions involved William B. Cyr directly and several indirect holdings: By Spouse, By Irrevocable Spousal Trust for Linda W. Cyr, and By Linda W. Cyr 2020 Irrevocable Trust for Descendants, each exercising options and selling shares of Freshpet common stock.

What does transaction code M mean in the Freshpet (FRPT) Form 4?

In this Form 4, transaction code M denotes the exercise or conversion of derivative securities (stock options) into Freshpet common stock at the stated $10.23 per share exercise price, followed in some cases by open-market sales coded as S.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/21/2026M62,369A$10.23350,862D
Common Stock08/21/2026S(1)40,957D$73.87(2)(3)309,905D
Common Stock08/24/2026M62,369A$10.23372,274D
Common Stock08/24/2026S(1)40,398D$76.01331,876D
Common Stock08/24/2026S(1)567D$74.03331,309D
Common Stock08/21/2026M4,620A$10.2342,091IBy Spouse
Common Stock08/21/2026S(1)639D$74.3441,452IBy Spouse
Common Stock08/24/2026M4,620A$10.2346,072IBy Spouse
Common Stock08/24/2026S(1)640D$74.0345,432IBy Spouse
Common Stock08/21/2026M9,030A$10.2392,937IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/21/2026S(1)1,247D$74.3491,690IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/24/2026M9,030A$10.23100,720IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/24/2026S(1)1,250D$74.0399,470IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/21/2026M7,981A$10.2384,673IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/21/2026S(1)1,102D$74.3483,571IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/24/2026M7,981A$10.2391,552IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/24/2026S(1)1,105D$74.0390,447IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2308/21/2026M62,369 (4)09/06/2026Common Stock62,369$0118,810D
Options to purchase common stock$10.2308/24/2026M62,369 (4)09/06/2026Common Stock62,369$056,441D
Options to purchase common stock$10.2308/21/2026M4,620 (4)09/06/2026Common Stock4,620$08,800IBy Spouse
Options to purchase common stock$10.2308/24/2026M4,620 (4)09/06/2026Common Stock4,620$04,180IBy Spouse
Options to purchase common stock$10.2308/21/2026M9,030 (4)09/06/2026Common Stock9,030$017,200IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2308/24/2026M9,030 (4)09/06/2026Common Stock9,030$08,170IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2308/21/2026M7,981 (4)09/06/2026Common Stock7,981$015,190IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Options to purchase common stock$10.2308/24/2026M7,981 (4)09/06/2026Common Stock7,981$07,209IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.819 to $73.874.
3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person08/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)